936348-52-6

Usage

Uses

Used in Medical Procedures:
Methyl 3-amino-4-((2-hydroxyethyl)amino)benzoate is used as a local anesthetic agent for medical procedures such as dental work, minor surgeries, and various diagnostic tests. It is effective in numbing the skin and mucous membranes, providing pain relief during these procedures.
Used in Pain Management:
Methyl 3-amino-4-((2-hydroxyethyl)amino)benzoate is used as a pain management tool in situations where local anesthesia is required. Its ability to block pain signals makes it a valuable asset in the management of pain during medical interventions.
Used in Allergy Considerations:
While Methyl 3-amino-4-((2-hydroxyethyl)amino)benzoate is generally safe, it is used with caution in individuals who may have an allergic reaction to it. Healthcare professionals are advised to assess patients for potential allergies before administering the anesthetic.
Used in Special Populations:
Methyl 3-amino-4-((2-hydroxyethyl)amino)benzoate is used with consideration for special populations, such as pregnant women and those with certain medical conditions. Its safety and efficacy in these groups are carefully evaluated to ensure appropriate use and minimize risks.

Upstream product

• 59320-15-9 4-(2-hydroxyethylamino)-3-nitro-benzoic acid methyl ester 

Relevant academic research and scientific papers

Diversity-Oriented Synthesis of Coumarin-Linked Benzimidazoles via a One-Pot, Three-Step, Intramolecular Knoevenagel Cyclization

Diversity-oriented synthesis of coumarin-linked benzimidazoles from N-(2-aminophenyl)-2-cyanoacetamide was achieved via a one-pot, three-step sequential reaction in excellent yields. In situ intramolecular cyclization of the cyanoacetamide afforded benzimidazoles which subsequently underwent a Knoevenagel condensation of the 2-cyanomethylbenzimidazoles with salicylaldehydes promoted by triethylamine to reach the target compounds. An important intermediate, 2-(2-imino-2H-chromen-3-yl)-1H-benzimidazole was characterized by X-ray analysis and further hydrolyzed to 2-(coumarin-3-yl)benzimidazole in acidic condition. Among the synthesized compounds, some were found to be promising inhibitors of porcine kidney d-amino acid oxidase (pkDAO).

PHARMACEUTICAL USE OF SUBSTITUTED AMIDES

The use of substituted amides for modulating the activity of 11-hydroxysteroid dehydrogenase type 1 (11HSD1) and the use of these compounds as pharmaceutical compositions, are described. Also a novel class of substituted amides, their use in therapy, pharmaceutical compositions comprising the compounds, as well as their use in the manufacture of medicaments are described. The present compounds are modulators and more specifically inhibitors of the activity of 11HSD1 and may be useful in the treatment, prevention and/or prophylaxis of a range of medical disorders where a decreased intracellular concentration of active glucocorticoid is desirable.